GeneProof Marks 20 Years of Molecular Diagnostics with New Innovations at MEDICA 2025
Posted on 17 Nov 2025
New innovations are on display as GeneProof marks 20 years in molecular diagnostics at MEDICA 2025 in Düsseldorf, Germany. At Booth J58 in Hall 3, the company is highlighting automated and open-platform systems that streamline sample-to-result workflows. Visitors can explore GeneProof’s latest advancements in PCR diagnostics and molecular solutions, designed to set new standards in accuracy and reliability.
At MEDICA 2025, GeneProof is showcasing the croGENE Real‑Time polymerase chain reaction (PCR) System, a high‑performance, open‑platform instrument for rapid and reliable molecular diagnostics. The system supports both qualitative and quantitative analysis and is optimized for use with GeneProof PCR kits. It features advanced temperature control and a high-sensitivity optical system to ensure accurate and consistent results. With capacity for up to 96 samples per run, it is well-suited for use in both diagnostic and research laboratories.
Also featured at the exhibit is myCROBE, a fully automated sample‑to‑result solution designed to run a broad spectrum of diagnostic tests. The system covers the entire workflow, from nucleic acid extraction, PCR setup (including automatic PCR plate sealing), PCR amplification to automatic result evaluation. By integrating sample preparation and real‑time PCR on a single platform, myCROBE reduces manual steps and helps standardize laboratory workflows.
Beyond instrumentation, the exhibit showcases GeneProof’s portfolio of next‑generation PCR kits and automation‑ready solutions for clinical laboratories seeking to improve accuracy, reliability, and throughput. At the company’s booth, GeneProof’s experts are available to provide insights on implementation and workflow optimization, including in-person demonstrations.
Related Links:
GeneProof
